SEC Contract Filing

Filing Date: 2024-09-03

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>pkbo-ex10_1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html>
 <head>
 <title>EX-10.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
 <div style="min-height:0.94in;"></div>
 <p style="font-size:10pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.741%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">SEPARATION AND GENERAL RELEASE AGREEMENT</font></p>
 <p style="margin-left:1.867%;text-indent:6.894%;font-size:10pt;margin-top:13.75pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.63%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">This Separation and General Release Agreement (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Agreemen</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">t&#x201d;) is entered into by and between Peak Bio, Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), and Stephen LaMond (referred to herein as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Employe</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">e&#x201d;), as of the last date set forth on the signature page hereof (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Execution Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) but effective as of the Effective Date defined in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Section 18</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">. The Company and Employee are referred to herein as the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Parties</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.&#x201d;</font></p>
 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
 <p style="margin-left:0.92%;text-indent:6.827%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.62%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WHEREAS, </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Employee is currently employed by the Company in the position of Interim Chief Executive Officer and Chief Operating Officer pursuant to the terms of his Offer Letter dated January 21, 2022 as amended on March 1, 2022, together with several consulting and employment offer letters between Employee and Peak Bio, Inc and pH Pharma, Inc. and signed by Employee (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Offer Letters</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;);</font></p>
 <p style="margin-left:0.92%;text-indent:6.831%;font-size:10pt;margin-top:12.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.676%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WHEREAS, </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Employee and the Company have mutually agreed that Employee&#x2019;s employment will terminate in accordance with the terms of this Agreement; and</font></p>
 <p style="margin-left:0.92%;text-indent:6.83%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WHEREAS, </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">the Parties wish to establish the terms of Employee&#x2019;s separation and resolve any and all disputes and demands that Employee may have against the Company as defined herein, including, but not limited to, any and all claims arising or in any way related to Employee&#x2019;s employment with, or separation from, the Company.</font></p>
 <p style="margin-left:0.92%;text-indent:6.829%;font-size:10pt;margin-top:12.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.657%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">NOW THEREFORE</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;fo